{"id":1001,"date":"2017-01-20T12:19:16","date_gmt":"2017-01-20T10:19:16","guid":{"rendered":"https:\/\/alzheimer.noemi.lu\/?p=1001"},"modified":"2017-01-20T12:19:16","modified_gmt":"2017-01-20T10:19:16","slug":"epad-welcomes-new-partner-roche","status":"publish","type":"post","link":"https:\/\/ep-ad.org\/index.php\/2017\/01\/20\/epad-welcomes-new-partner-roche\/","title":{"rendered":"EPAD welcomes new partner Roche"},"content":{"rendered":"<p>We are pleased to announce the arrival of a new project partner, Roche. We say a warm welcome to Roche and look forward to our collaboration.<\/p>\n<p>The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n\u00b0 115736, resources of which are composed of financial contribution from the European Union&#8217;s Seventh Framework Programme (FP7\/2007-2013) and EFPIA companies\u2019 in kind contribution.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are pleased to announce the arrival of a new project partner, Roche. We say a warm welcome to Roche and look forward to our collaboration. The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n\u00b0 115736, resources of which are composed of financial contribution from the European [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":980,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1001","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/1001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=1001"}],"version-history":[{"count":0,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/1001\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media\/980"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=1001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/categories?post=1001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/tags?post=1001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}